+ Part III · Resin to device

From resin to the device in use.

The material in a patient's device is not the pellet in the supplier's bag. Heat and pressure shape the pellet into a part, solvents or adhesives join that part to others, and fluids clean the assembly. A sterilant may then pass through the device, a package holds it for months or years, and a device used at home is cleaned again by its user. Each step changes what the material holds and what it can release. Chapter 6 follows a part from pellet to assembled device, and Chapter 7 follows the finished device through sterilization, packaging, aging and cleaning. Both chapters lead to one rule: what is evaluated is the finished device, as it reaches the patient and as it stays in use.

06 — Making the part

From pellet to part.

+ The questionWhat do molding, bonding and cleaning add to a material?

The melt breaks chains and spends antioxidant

A molded part leaves the press carrying traces of what the press did to it and of what the press used. The first change happens in the melt, where heat and flow act on the chains themselves. In a molding press or an extruder, a turning screw pushes the melt along, and one layer drags past the next. That dragging is shear: it stretches chains that heat has already set moving, and some of them break. When a polypropylene chain breaks, the break "generates double bonds and free radicals". The radicals are highly reactive broken ends, and they "react with oxygen to produce peroxides and hydroperoxides", which break further chains, so the damage feeds itself.

Alotaibi and colleagues describe that chain of reactions, and in a 2022 bench study they measured its result. They passed one grade of polypropylene three times through laboratory extruders at 200 to 230 °C and measured how readily the melt flowed. A melt flows more readily as its chains get shorter, so a rise in flow marks broken chains. The twin-screw extruder ran at three screw speeds. At the highest, the melt's flow rose over the three passes from 2.5 to 5.1 times that of the unprocessed resin, and at the lowest from 1.3 to 2.0 times. More shear broke more chains, and each further pass broke more.

Antioxidants are in the recipe to interrupt that reaction, and they are used up doing it. In a 2018 bench study of one polyethylene, Allen and colleagues followed two of them through five passes of a laboratory extruder. The first, a phosphite, breaks down hydroperoxides before they split more chains. It was consumed first and became its phosphate, a transformation product: a new molecule made from an additive during processing. The second, a hindered phenol, stops the radical reaction directly, and it was consumed more slowly, more slowly still with the phosphite there to protect it. Two companies, Repsol and Chemtura, partly funded the study, and two of its authors worked for companies, Element and Repsol.

Solved example: how much one melting turns into a new molecule
  • The start. In the blend Allen and colleagues tested, the polyethylene carried 1,000 parts per million each of the phosphite and the phenol, a tenth of a percent of each.
  • One pass. The first extrusion consumed 40 % of the phosphite: 400 of its 1,000 parts per million, leaving 600.
  • What it became. The consumed phosphite converts to its phosphate, which the study measured in the polymer.
  • The result. After a single melting, the material holds a phosphate formed from 400 parts per million of phosphite, or four parts in every 10,000 of the polymer. Its recipe lists the phosphite, not the phosphate.
  • Assumptions. The study used one polyethylene, one blend and a laboratory extruder, not a molding press. It measured the phosphate in the polymer, not whether the phosphate leaves a part. An extraction of the finished part asks that question (Chapter 12).
17 — One melt makes a new molecule
BEFORE — THE BLEND AS MADE the recipe lists both phosphite: 1,000 ppm phenol: 1,000 ppm one pass through a laboratory extruder AFTER — ONE MELT the recipe lists the phosphite, not the phosphate phosphite left: 600 ppm its phosphate, formed from 400 ppm of phosphite phenol: consumed more slowly; no count shown a new molecule, made in the melt, on no recipe phosphite after one pass: 600 left, 400 consumed, of 1,000 ppm 400 ppm: four parts in every 10,000 of the polymer Schematic; one dot for 100 ppm. Allen and colleagues, 2018 (bench study partly funded by two companies; two authors company staff): one polyethylene in a laboratory extruder, not a molding press; 40 % of the phosphite consumed in the first extrusion; the phosphate measured in the polymer, not as a leachable.
Device materialReleased substanceFocal detail
Plate 17 — One pass through a laboratory extruder consumed 40 % of the phosphite in a polyethylene blend, 400 of its 1,000 parts per million, and the phosphite became its phosphate. The polymer leaves the melt carrying a molecule that its recipe does not list.

Both studies used laboratory extruders, and molding itself has been measured on polycarbonate. In bench tests reported in a 1996 trade-magazine article, Hong and colleagues found that injection molding slightly lowered the average molar mass of polycarbonate chains between pellet and molded bar. They attributed the loss to thermal degradation. All three authors were staff of the device maker Baxter Healthcare.

Short chains form in the melt

Heat can also make short chains, the oligomers of Chapter 3, where there were none. Those short chains matter because small molecules move through a plastic more readily than large ones (Chapter 4). A melt of polyethylene terephthalate, PET, the plastic of drink bottles, can form ring-shaped oligomers, a point that Diamantidou and colleagues cite from earlier work: "Even in cyclic-oligomer-free PET, the formation of cyclic oligomers from the melt might occur at a significant level." Their own 2023 bench study did not measure that formation; it measured rings of two, three and four repeating units leaving bottles. The bottles were held in 95 % ethanol at 60 °C for 10 days, conditions far harsher than a bottle of water meets. Under them the trimer, the ring of three units, was the main migrant, so the rings that a melt can form are rings that can leave.

No one added those rings to the recipe, and the authors class oligomers as "a particular category of non-intentionally added substances (NIAS)". A non-intentionally added substance is any substance in a material that nobody put there on purpose: a fragment of the polymer, a by-product of a reaction, or a transformation product such as the antioxidant's phosphate. A resin's recipe lists what its maker added, so it cannot list what a later melt makes. The evidence is from bottles, but a press that shapes a medical housing melts its polymer too, and what that melt makes belongs to the part.

What the mold, the joints and the wash leave behind

Processing also leaves what was never meant to stay: a mold release agent that frees a part from the mold, joining solvents and adhesives, and inks that print scales and labels. In a 2023 resource page on documenting device components, FDA asks makers to account for every added chemical, "plasticizers, fillers, additives, cleaning agents, mold release agents". It also asks them to document "any joining processes/materials (for example, adhesives or sintering processes)". A residue is whatever the making of a part leaves in or on it without meaning to: the monomer and catalyst of Chapter 3, and here the release agents, solvents, adhesives and cleaning fluids of processing. Unless it has reacted into the chains, a residue can diffuse out like any unbound additive (Chapter 4).

One processing solvent has been measured both in fluid from device plastics and in the blood of patients. Cyclohexanone bonds medical plastic parts, such as intravenous tubing to stopcocks and bags, and it migrates easily from PVC tubing into intravenous fluids, as Everett and colleagues explain in the background to their 2020 study. In a 2009 study of fluids and of 49 rats, Thompson-Torgerson and colleagues at Johns Hopkins found cyclohexanone in fluid from intravenous bags at about 10 to 3,700 µg/L. They describe it as a solvent used in making the plastics of such bags and of extracorporeal circuits, the tubing that carries blood outside the body. In the rats, cyclohexanone lowered blood pressure, the force of the heart's contraction, cardiac output and heart rate. It also raised pressure in the lungs' circulation and caused edema, a build-up of fluid in tissue.

Everett and colleagues then measured the solvent in patients, in a secondary analysis of a randomized trial. Their 85 newborns had heart surgery on cardiopulmonary bypass at one center between 2012 and 2016. The median concentration of cyclohexanone in the newborns' serum rose about threefold, from 572 µg/L before the first incision to 1,744 µg/L immediately after the operation. Newborns with higher exposure scored lower on tests of cognition and language at 12 months, while the difference in motor scores was not statistically significant. The authors report the link as an association, and the study did not test whether the solvent caused the lower scores. Nor did it trace the solvent in the newborns' serum to one part of the circuit. Neither the 2009 nor the 2020 study had a company funder or a company author.

Cleaning after assembly removes some residues and can add its own. FDA counts "Manufacturing Residuals (e.g., oils, cleaning fluids)" among the risks of device materials, in slides on its 2024 draft guidance on chemical analysis. The draft is not final. A test article is the sample tested in place of the device. Under ISO 10993-12, the standard on preparing samples, the test article accounts for "Any residue from the manufacturing processes, intentional or unintentional additives or contaminants", in a clause that FDA's slides quote. For the worst case, FDA proposes taking the test article from the process that leaves the most residue, such as cleaning with a detergent, or from one that makes the material release more extractables, such as heating a polymer during molding.

18 — What each step from pellet to part adds
PELLET — AS SUPPLIED MELT — HEAT AND SHEAR MOLD JOIN CLEAN the recipe of Chapter 3; antioxidant among the dots chains broken: melt flows 5.1 times as readily after 3 passes at the highest screw speed (polypropylene) antioxidant spent: 40 % of the phosphite gone after one pass (polyethylene) ring oligomers can form (PET) mold release agent solvent or adhesive at the joint cyclohexanone: a processing solvent found in IV-bag fluid cleaning fluids and oils ADDED AFTER THE RESIN LEFT ITS SUPPLIER the part as made: what the evaluation tests Schematic; chain and dot counts illustrative. Chains and melt flow: Alotaibi and colleagues, 2022 (extrusion); antioxidant: Allen and colleagues, 2018 (extrusion); oligomers: Diamantidou and colleagues, 2023 (PET bottles); cyclohexanone: Thompson-Torgerson and colleagues, 2009; residue kinds: FDA (2023 resource page; slides on the 2024 draft guidance).
Device materialReleased substanceGas or fluid pathFocal detail
Plate 18 — Each step from pellet to part adds to what the part can release: broken chains, spent antioxidant and oligomers from the melt, then mold release agent, joining solvent or adhesive, and cleaning residues. None of them is on the resin's recipe, so the evaluation tests the part as made.

A new color or a new supplier makes a new material

A colorant is an additive (Chapter 3), so a new color changes the recipe of the material. In its 2017 guidance on when a change to a device needs a new premarket notification, FDA asks of a material change: "Is this a change in material type, material formulation, chemical composition, or the material's processing?" A new colorant changes the formulation, so on this book's reading a color change is a material change, whatever the resin is called.

A new supplier changes a material in the same way while its name stays, and Chapter 3 showed that a change of supplier can affect biocompatibility. Changes of supplier or of specification "could introduce" different or additional residues, and some resin changes may change a material's physical properties or surface, as FDA states on its 2023 resource page. For two grades of one trade-named resin, FDA asks the file to state that the grades "vary only in the concentration of specific formulation components". In FDA's example, a novel component or a higher concentration may need a new risk assessment or testing. Chapter 23 takes up how a quality system evaluates such a change, whatever the base material's history of safe use.

The evaluation covers the part as made

Every step in this chapter acts on the material after its supplier described it (Chapter 3). Each step changes what the part holds or the surface it presents, so the thing evaluated is the part as made. FDA compares a test article with the device "in its final finished form", and the match covers formulation, processing, sterilization and geometry. Processing reaches the surface as well, in FDA's words: "The impact of surface alterations due to processing, even at the micron or submicron level, should be evaluated." Among the factors that change what a device releases, FDA's slides on its draft also count sterilization, cleaning or rinsing by the user before first use, and for some devices the shelf life (Chapter 7).

Three parts of the running device show what making adds. The water chamber is polycarbonate, by this book's choice in Chapter 3, and it is molded in one shot. It can therefore carry the short chains, oligomers and transformation products that a melt makes, and the heated water it holds draws such small molecules out faster (Chapter 4). The hose cuff is a thermoplastic elastomer like the hose and is bonded to it, so the cuff may hold the bonding solvent or adhesive. The sound-damping foam is die-cut from a slab and glued into the blower housing. Its adhesive and its cut faces therefore sit in the air path, where only what evaporates or breaks off can reach the patient (Chapters 5 and 19).

In practice

For each part that touches the patient or the gas path, list what the factory adds to the resin's recipe: melt temperature and number of meltings, mold release agent, solvent, adhesive or ink, cleaning agent and rinse, colorant, and the resin's supplier and grade. Make test articles from production parts, not from the resin alone. For the running device, record the chamber's molding conditions, the cuff's bonding agent and the foam's adhesive and cutting step, and treat a change to any entry as a change to the material (Chapter 23).

+ What this chapter established
  • Heat and shear in the melt can break chains and use up antioxidants, so a part can leave the press with shorter chains and with transformation products that its resin's recipe does not list.
  • The melt can also form oligomers that no one added on purpose, such as the rings that migrate from PET bottles.
  • Molding, joining and cleaning leave residues, and one processing solvent, cyclohexanone, rose in newborns' serum during heart surgery, and in those newborns higher exposure was associated with lower cognitive and language scores.
  • A new colorant or a new supplier changes a material's formulation even when the resin's name stays, so the test article is taken from the part as made.
Created with Claude (Anthropic).
Educational reference material, not engineering, regulatory or clinical advice. Product and company names referenced are the property of their respective owners.